Benefits to sperm parameters only maintained with persistent weight loss at 52 weeks
WEDNESDAY, Aug. 24, 2022 (HealthDay News) — Sperm concentration and sperm count are improved in men with obesity after diet-induced weight loss, according to a study published in the July issue of Human Reproduction.
Emil Andersen, from University of Copenhagen in Denmark, and colleagues examined acute and long-term effects of weight loss on semen parameters. The analysis included 56 men with obesity assigned to an initial eight-week low-calorie diet (800 kcal/day), followed by randomization to 52 weeks of placebo and habitual activity (placebo), exercise training and placebo (exercise), the Glucagon Like Peptide 1 (GLP-1) analogue liraglutide and habitual activity (liraglutide), or liraglutide in combination with exercise training (combination).
The researchers found that men lost on average 16.5 kg body weight with the low-calorie diet, which increased sperm concentration 1.49-fold and sperm count 1.41-fold. For men who maintained the weight loss, these improvements were maintained for 52 weeks, but improvements were not maintained in men who regained weight. No changes were seen in semen volume, sperm motility, or motile sperm count.
“The persistent improvement of sperm concentration and count after weight loss maintained through exercise and/or a GLP-1 receptor agonist may therefore also result in improved male fertility,” the authors write.
The study was supported by a grant from the Novo Nordisk Foundation, and several authors disclosed financial ties to Novo Nordisk.
Sleep Coaching No Aid for Glucose Beyond Diabetes Lifestyle Program
Study Looks at Approaches to Prescribing Obesity Medications for Older Adults
Bariatric Surgery Is Effective Rescue Strategy After GLP-1 Receptor Agonist Failure
Weight-Loss Surgery Produces Lasting Diabetes Remission
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria
Spinal Cord Stimulation Cuts Pain, Improves Sensation With Diabetic Nerve Damage
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50